Benefits from new ADP antagonists as compared with clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a …
M Verdoia, A Schaffer, L Barbieri… - Journal of …, 2014 - journals.lww.com
Aims: New P2Y12 receptor inhibitors have provided new and more potent antiplatelet
strategies, although raising several concerns on possible increase of bleedings. The aim of …
strategies, although raising several concerns on possible increase of bleedings. The aim of …
Benefits from new ADP antagonists as compared with clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a …
M Verdoia, A Schaffer, L Barbieri, E Cassetti… - Journal of …, 2014 - europepmc.org
Aims New P2Y12 receptor inhibitors have provided new and more potent antiplatelet
strategies, although raising several concerns on possible increase of bleedings. The aim of …
strategies, although raising several concerns on possible increase of bleedings. The aim of …
[PDF][PDF] Benefits from new ADP-antagonists as compared to clopidogrel in patients with stable angina or acute coronary syndrome: a meta-analysis of randomized trials
M Verdoia, A Schaffer, L Barbieri, E Cassetti… - PDF hosted at the …, 2014 - core.ac.uk
Abstract Aims. New P2Y12 receptor inhibitors has provided new and more potent
antiplatelet strategies, although raising several concerns on possible increase of bleedings …
antiplatelet strategies, although raising several concerns on possible increase of bleedings …
Benefits from new ADP antagonists as compared with clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a …
M Verdoia, A Schaffer, L Barbieri… - Journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
Aims New P2Y12 receptor inhibitors have provided new and more potent antiplatelet
strategies, although raising several concerns on possible increase of bleedings. The aim of …
strategies, although raising several concerns on possible increase of bleedings. The aim of …
[PDF][PDF] Benefits from new ADP-antagonists as compared to clopidogrel in patients with stable angina or acute coronary syndrome: a meta-analysis of randomized trials
M Verdoia, A Schaffer, L Barbieri… - … therapies in coronary …, 2014 - repository.ubn.ru.nl
Abstract Aims. New P2Y12 receptor inhibitors has provided new and more potent
antiplatelet strategies, although raising several concerns on possible increase of bleedings …
antiplatelet strategies, although raising several concerns on possible increase of bleedings …
Benefits from new ADP-antagonists as compared to clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta …
M Verdoia, A Schaffer, L Barbieri, E Cassetti… - JOURNAL OF …, 2014 - iris.uniupo.it
AIMS: New P2Y12 receptor inhibitors have provided new and more potent antiplatelet
strategies, although raising several concerns on possible increase of bleedings. The aim of …
strategies, although raising several concerns on possible increase of bleedings. The aim of …
Benefits from new ADP antagonists as compared with clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: A …
M Verdoia, A Schaffer, L Barbieri, E Cassetti… - JOURNAL OF …, 2014 - iris.unisa.it
Aims: New P2Y12 receptor inhibitors have provided new and more potent antiplatelet
strategies, although raising several concerns on possible increase of bleedings. The aim of …
strategies, although raising several concerns on possible increase of bleedings. The aim of …
Benefits from new ADP antagonists as compared with clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: A …
M Verdoia, A Schaffer, L Barbieri… - Journal of …, 2014 - research.uniupo.it
Aims: New P2Y12 receptor inhibitors have provided new and more potent antiplatelet
strategies, although raising several concerns on possible increase of bleedings. The aim of …
strategies, although raising several concerns on possible increase of bleedings. The aim of …
Benefits from new ADP antagonists as compared with clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: A …
M Verdoia, A Schaffer, L Barbieri… - Journal of …, 2014 - research.uniupo.it
Aims: New P2Y12 receptor inhibitors have provided new and more potent antiplatelet
strategies, although raising several concerns on possible increase of bleedings. The aim of …
strategies, although raising several concerns on possible increase of bleedings. The aim of …
[PDF][PDF] Benefits from new ADP-antagonists as compared to clopidogrel in patients with stable angina or acute coronary syndrome: a meta-analysis of randomized trials
M Verdoia, A Schaffer, L Barbieri… - … therapies in coronary …, 2014 - repository.ubn.ru.nl
Abstract Aims. New P2Y12 receptor inhibitors has provided new and more potent
antiplatelet strategies, although raising several concerns on possible increase of bleedings …
antiplatelet strategies, although raising several concerns on possible increase of bleedings …